Literature DB >> 20525941

Clinical outcome and magnetic resonance imaging findings in infants with hypoglycemia.

Hüseyin Caksen1, Ahmet Sami Güven, Cahide Yilmaz, Ozkan Unal, Murat Basaranoglu, Ertan Sal, Avni Kaya.   

Abstract

The authors examined clinical outcome and cranial magnetic resonance imaging (MRI) findings in infants with hypoglycemia to determine the effects of hypoglycemia on the developing brain. A total of 110 infants with hypoglycemia were included in the study. Of the patients, 36 were females and 74 were males. The age of the infants was between 1 day and 22 months. Of the 110 infants, 47 were preterm neonates, 40 were term neonates, and 23 were older than 28 days. No difference in serum glucose level was noted between symptomatic and asymptomatic infants. The most common observed abnormal findings were hyperintense lesions, encephalomalacia, and cerebral atrophy. Abnormal MRI findings were found in 4% of preterm infants, in 32.5% of term infants, and in 43.5% of older infants. Abnormal MRI findings were statistically significantly more common in symptomatic infants than in asymptomatic infants. Of the infants, 45.5% of hypoglycemic infants had cerebral palsy and/or cerebral palsy plus epilepsy.

Entities:  

Mesh:

Year:  2010        PMID: 20525941     DOI: 10.1177/0883073810371508

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

Review 1.  Glucose control during labor and delivery.

Authors:  Edmond A Ryan; Rany Al-Agha
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

2.  Cost Analysis of Cot-Side Screening Methods for Neonatal Hypoglycaemia.

Authors:  Matthew J Glasgow; Jane E Harding; Richard Edlin
Journal:  Neonatology       Date:  2018-06-12       Impact factor: 4.035

3.  Comparison of risk-of-bias assessment approaches for selection of studies reporting prevalence for economic analyses.

Authors:  Matthew J Glasgow; Richard Edlin; Jane E Harding
Journal:  BMJ Open       Date:  2020-09-16       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.